Core Viewpoint - A class action lawsuit has been filed against Gauzy Ltd. for alleged violations of federal securities laws, impacting investors who acquired Gauzy securities between March 11, 2025, and November 13, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit seeks to recover damages for investors who purchased Gauzy securities during the specified class period [2]. - The Complaint alleges that Gauzy's officers made materially false and misleading statements and failed to disclose adverse facts about the Company's business and operations [3]. - Specific allegations include that three of Gauzy's French subsidiaries lacked the financial means to meet their debts, indicating a likelihood of insolvency proceedings and potential defaults under existing debt facilities [7]. Group 2: Investor Participation - Investors who suffered losses in Gauzy have until February 6, 2026, to request appointment as lead plaintiff in the class action [3]. - Participation in any recovery does not require serving as lead plaintiff [3]. Group 3: Legal Representation - Bronstein, Gewirtz & Grossman, LLC represents investors on a contingency fee basis, meaning they will only collect fees if successful in recovering damages [4]. - The firm has a history of recovering hundreds of millions of dollars for investors in securities fraud cases [5].

Core Viewpoint - A class action securities lawsuit has been filed against James Hardie Industries plc, alleging securities fraud that negatively impacted investors between May 20, 2025, and August 18, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that James Hardie Industries made false statements and concealed adverse facts regarding its North America segment, including deteriorating consumer demand and growth being driven by overstocking rather than actual demand [2]. - Excessive inventory at James Hardie's North America distributors is highlighted as a significant issue resulting from the alleged misrepresentation of growth drivers [2]. Group 2: Investor Information - Investors who suffered losses during the specified period have until December 23, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require serving in this role [3]. - Class members may be entitled to compensation without incurring any out-of-pocket costs or fees, emphasizing that there is no financial obligation to participate [3]. Group 3: Legal Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years and consistently ranking among the top securities litigation firms in the United States [4].

Core Viewpoint - Freeport-McMoRan Inc. is facing a class action lawsuit for securities fraud, which has resulted in significant stock price drops due to alleged violations of federal securities laws [1][3]. Group 1: Lawsuit Details - A class action lawsuit has been filed against Freeport-McMoRan and certain senior executives, asserting claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [3]. - Investors have until January 12, 2026, to request to lead the case, which is pending in the U.S. District Court for the District of Arizona [3]. - The lawsuit alleges that Freeport overstated its commitment to safety while conducting unsafe mining practices at the Grasberg mine, which could lead to worker fatalities [5]. Group 2: Stock Price Impact - On September 9, 2025, Freeport's stock dropped by $2.77 per share (over 5.9%) following a press release about suspended mining operations due to a landslide [6]. - Following an update on September 24, 2025, indicating two fatalities and a projected 4% drop in copper sales and 6% drop in gold sales, the stock fell by $7.69 per share (almost 17%) [7]. - Additional reports on September 25, 2025, regarding strained relations with the Indonesian government led to a further decline of $2.33 per share (over 6%) [9]. - An Indonesian news report on September 28, 2025, claimed the incident was preventable, further impacting investor confidence [10].

Core Viewpoint - Lantheus Holdings, Inc. is a significant player in the diagnostic medical imaging sector, facing legal challenges but showing resilience in stock performance and potential for growth [1][3][5]. Company Overview - Lantheus Holdings, Inc. specializes in developing and commercializing diagnostic medical imaging agents and products, operating within the healthcare sector [1]. - The company holds a substantial market position despite competition in the medical imaging industry [1]. Stock Performance - As of December 11, 2025, the stock price of LNTH was $63.09, with a price target set by Truist Financial at $80, indicating a potential increase of approximately 26.8% [2][6]. - The stock has fluctuated between $61.21 and $63.195 during the trading day, with a yearly high of $111.29 and a low of $47.25 [4]. - The market capitalization of Lantheus is approximately $4.32 billion, reflecting its significant presence in the market [4]. Legal Challenges - The company is currently under investigation by Grabar Law Office for potential breaches of fiduciary duties, which is part of a broader federal securities fraud class action complaint [2][3][6]. - Shareholders who purchased shares before November 6, 2024, may seek corporate reforms and financial restitution due to the ongoing legal scrutiny [3]. Investor Interest - The trading volume for LNTH on the NASDAQ exchange is 914,143 shares, indicating active investor interest despite the legal challenges [5]. - The stock has shown resilience with a recent increase of 3.73%, reaching $63.09 [3][6].

Core Viewpoint - A class action lawsuit has been filed against Gauzy Ltd. for alleged violations of federal securities laws during the specified class period, seeking to recover damages for affected investors [1][2]. Summary by Sections Lawsuit Details - The lawsuit targets Gauzy Ltd. and certain officers for making materially false and misleading statements and failing to disclose adverse facts about the company's business and operations during the class period from March 11, 2025, to November 13, 2025 [2][3]. - Specific allegations include the failure to disclose that three of the company's French subsidiaries lacked the financial means to meet their debts, which could lead to insolvency proceedings and potential defaults under existing senior secured debt facilities [8]. Investor Participation - Investors who purchased Gauzy securities during the class period are encouraged to join the lawsuit, with a deadline to request lead plaintiff status by February 6, 2026 [3]. - Participation in any recovery does not require serving as the lead plaintiff [3]. Legal Representation - Bronstein, Gewirtz & Grossman, LLC represents investors on a contingency fee basis, meaning they will only seek reimbursement for expenses and fees if successful in the lawsuit [4]. - The firm has a history of recovering hundreds of millions of dollars for investors in similar cases [5]. Firm's Mission - The firm emphasizes its commitment to restoring investor capital and ensuring corporate accountability to maintain market integrity [6].

Core Viewpoint - A class action lawsuit has been filed against CarMax, Inc. and certain senior executives for securities fraud following a significant stock drop attributed to potential violations of federal securities laws [1][2]. Group 1: Lawsuit Details - Investors have until January 2, 2026, to request to lead the case, which is pending in the U.S. District Court for the District of Maryland [2]. - The lawsuit asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of CarMax investors [2]. Group 2: Company Performance and Stock Impact - CarMax reported disappointing financial results for Q2 of fiscal year 2026, including a 5.4% decline in retail used unit sales, a 6.3% decline in comparable store used unit sales, and a 2.2% decline in wholesale units [5]. - The company's net income for Q2 was approximately $95.4 million, down from $132.8 million the previous year, attributed to a "pull forward" in demand due to U.S. tariffs [5]. - Following the financial report, CarMax's stock dropped $11.45 per share, or roughly 20%, from $57.05 on September 24, 2025, to $45.60 on September 25, 2025 [6]. - An unexpected departure of CEO Bill Nash on November 6, 2025, and a weak preliminary Q3 outlook led to an additional stock drop of over 24% [6]. Group 3: Company Background - CarMax is a leading retailer of used cars, emphasizing a seamless customer experience and strong demand for its vehicles [3]. - The law firm Bleichmar Fonti & Auld LLP, which is representing the plaintiffs, has a strong track record in securities class actions, having recovered significant amounts from other companies [10].

Core Viewpoint - Fiserv, Inc. is facing a securities fraud class action lawsuit due to misleading statements and omissions regarding its business initiatives during the specified class period [3][4]. Summary by Sections Lawsuit Details - The lawsuit is on behalf of investors who purchased Fiserv securities from July 23, 2025, to October 29, 2025 [3]. - Allegations include that Fiserv made misleading statements about its initiatives and projects [3]. Impact on Stock Price - On October 29, 2025, Fiserv disclosed that its 2025 guidance was based on assumptions that were difficult to achieve, leading to a significant stock price drop of $55.57, or approximately 44%, from $126.17 to $70.60 [4]. Investor Actions - Investors who suffered losses on Fiserv investments have until January 5, 2026, to request lead plaintiff appointment [2]. - The law firm Kirby McInerney LLP is encouraging affected investors to contact them for discussions regarding their rights at no cost [1][4].

Core Viewpoint - A class action securities lawsuit has been filed against Primo Brands Corporation / Primo Water Corporation, alleging securities fraud that affected investors between June 17, 2024, and November 6, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit aims to recover losses for investors who were adversely affected by alleged securities fraud during the specified period [2]. - The complaint states that the defendants made false statements and concealed issues regarding the merger integration between Primo Water and BlueTriton Brands, which was reportedly tracking poorly due to technology and service issues [3]. - Contrary to the defendants' claims of a "flawless" execution, significant supply disruptions were occurring, negatively impacting customers and the financial results of Primo Brands [3]. Group 2: Next Steps for Investors - Investors who suffered losses during the relevant timeframe have until January 12, 2026, to request to be appointed as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [4]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, with no obligation to participate [4]. Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and has extensive expertise in complex securities litigation [5]. - The firm has been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years as one of the leading securities litigation firms in the United States [5].

Core Viewpoint - A class action lawsuit has been filed against CarMax, Inc. and certain senior executives for securities fraud following a significant stock drop attributed to potential violations of federal securities laws [1][2]. Group 1: Lawsuit Details - Investors have until January 2, 2026, to request to lead the case, which is pending in the U.S. District Court for the District of Maryland [2]. - The lawsuit asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of CarMax investors [2]. Group 2: Company Performance and Stock Impact - CarMax reported disappointing financial results for Q2 FY 2026, including a 5.4% decline in retail used unit sales, a 6.3% decline in comparable store used unit sales, and a 2.2% decline in wholesale units [5]. - The company's net income for Q2 was approximately $95.4 million, down from $132.8 million the previous year [5]. - Following the announcement of these results, CarMax's stock dropped $11.45 per share, or roughly 20%, from $57.05 on September 24, 2025, to $45.60 on September 25, 2025 [6]. - An unexpected departure of CEO Bill Nash on November 6, 2025, and a weak preliminary Q3 2025 outlook led to an additional stock drop of over 24% [6]. Group 3: Market Context - CarMax's previous claims of strong demand were allegedly inflated due to a temporary boost from U.S. tariffs on cars, which led to a "pull forward" in demand [3][5]. - The lawsuit and stock performance issues highlight potential concerns regarding the company's assessment of its portfolio of car loans [4].

Core Insights - Inspire Medical Systems, Inc. specializes in innovative medical solutions for sleep apnea treatments, particularly through its Inspire therapy device, which serves as an alternative to CPAP machines [1] - Piper Sandler has set a price target of $165 for INSP, indicating a potential upside of 20.61% from the current trading price of $136.81 [1][6] Legal Issues - Inspire Medical is currently facing a class action lawsuit led by the Schall Law Firm, alleging violations of the Securities Exchange Act of 1934 related to securities fraud [2][5] - The lawsuit targets investors who purchased INSP securities between August 6, 2024, and August 4, 2025, with affected shareholders encouraged to contact the law firm by January 5, 2026 [3] Stock Performance - As of the latest update, INSP's stock price is $136.81, reflecting a decrease of 2.30% or $3.22, with trading fluctuations between $136.61 and $142.26 [4] - Over the past year, INSP has experienced significant volatility, with a high of $216.01 and a low of $70.77, and currently holds a market capitalization of approximately $4.05 billion [4][6]